Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

926 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
New insights into the role of endosomal proteins for African swine fever virus infection.
Cuesta-Geijo MÁ, García-Dorival I, Del Puerto A, Urquiza J, Galindo I, Barrado-Gil L, Lasala F, Cayuela A, Sorzano COS, Gil C, Delgado R, Alonso C. Cuesta-Geijo MÁ, et al. Among authors: gil c. PLoS Pathog. 2022 Jan 26;18(1):e1009784. doi: 10.1371/journal.ppat.1009784. eCollection 2022 Jan. PLoS Pathog. 2022. PMID: 35081156 Free PMC article.
COVID-19: Drug Targets and Potential Treatments.
Gil C, Ginex T, Maestro I, Nozal V, Barrado-Gil L, Cuesta-Geijo MÁ, Urquiza J, Ramírez D, Alonso C, Campillo NE, Martinez A. Gil C, et al. J Med Chem. 2020 Nov 12;63(21):12359-12386. doi: 10.1021/acs.jmedchem.0c00606. Epub 2020 Jun 26. J Med Chem. 2020. PMID: 32511912 Free article. Review.
Identification of potential inhibitors of protein-protein interaction useful to fight against Ebola and other highly pathogenic viruses.
Lasala F, García-Rubia A, Requena C, Galindo I, Cuesta-Geijo MA, García-Dorival I, Bueno P, Labiod N, Luczkowiak J, Martinez A, Campillo NE, Alonso C, Delgado R, Gil C. Lasala F, et al. Among authors: gil c. Antiviral Res. 2021 Feb;186:105011. doi: 10.1016/j.antiviral.2021.105011. Epub 2021 Jan 8. Antiviral Res. 2021. PMID: 33428961 Free PMC article.
Identification of Niemann-Pick C1 protein as a potential novel SARS-CoV-2 intracellular target.
García-Dorival I, Cuesta-Geijo MÁ, Barrado-Gil L, Galindo I, Garaigorta U, Urquiza J, Puerto AD, Campillo NE, Martínez A, Gastaminza P, Gil C, Alonso C. García-Dorival I, et al. Among authors: gil c. Antiviral Res. 2021 Oct;194:105167. doi: 10.1016/j.antiviral.2021.105167. Epub 2021 Aug 24. Antiviral Res. 2021. PMID: 34450201 Free PMC article.
N'-Phenylacetohydrazide Derivatives as Potent Ebola Virus Entry Inhibitors with an Improved Pharmacokinetic Profile.
Garcia-Rubia A, Lasala F, Ginex T, Morales-Tenorio M, Olal C, Heung M, Oquist P, Galindo I, Cuesta-Geijo MÁ, Casasnovas JM, Campillo NE, Canales Á, Alonso C, Martínez A, Muñoz-Fontela C, Delgado R, Gil C. Garcia-Rubia A, et al. Among authors: gil c. J Med Chem. 2023 Apr 27;66(8):5465-5483. doi: 10.1021/acs.jmedchem.2c01785. Epub 2023 Apr 6. J Med Chem. 2023. PMID: 37021830 Free PMC article.
Kinase Inhibitors as Underexplored Antiviral Agents.
García-Cárceles J, Caballero E, Gil C, Martínez A. García-Cárceles J, et al. Among authors: gil c. J Med Chem. 2022 Jan 27;65(2):935-954. doi: 10.1021/acs.jmedchem.1c00302. Epub 2021 May 10. J Med Chem. 2022. PMID: 33970631 Free PMC article. Review.
The structural role of SARS-CoV-2 genetic background in the emergence and success of spike mutations: The case of the spike A222V mutation.
Ginex T, Marco-Marín C, Wieczór M, Mata CP, Krieger J, Ruiz-Rodriguez P, López-Redondo ML, Francés-Gómez C, Melero R, Sánchez-Sorzano CÓ, Martínez M, Gougeard N, Forcada-Nadal A, Zamora-Caballero S, Gozalbo-Rovira R, Sanz-Frasquet C, Arranz R, Bravo J, Rubio V, Marina A; IBV-Covid19-Pipeline; Geller R, Comas I, Gil C, Coscolla M, Orozco M, Llácer JL, Carazo JM. Ginex T, et al. Among authors: gil c. PLoS Pathog. 2022 Jul 11;18(7):e1010631. doi: 10.1371/journal.ppat.1010631. eCollection 2022 Jul. PLoS Pathog. 2022. PMID: 35816514 Free PMC article.
926 results